{
    "2021-03-13": [
        [
            {
                "time": "",
                "original_text": "疫苗被喊停阿斯利康以试验数据“自证清白”国内合作方康泰生物着手开展临床试验 经营问题",
                "features": {
                    "keywords": [
                        "疫苗",
                        "阿斯利康",
                        "试验数据",
                        "康泰生物",
                        "临床试验",
                        "经营问题"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：即将在国内开展阿斯利康新冠疫苗的临床试验",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "阿斯利康",
                        "新冠疫苗",
                        "临床试验"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}